• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

滤泡状甲状腺癌合并乳头状甲状腺癌的临床病理特征

Clinicopathological features of follicular thyroid carcinoma coexisting with papillary thyroid carcinoma.

作者信息

Hong-Qun Wang, Ya-Qi Ma, Ying Li, Huai-Yin Shi

机构信息

Department of Pathology, the Third People's Hospital of Bengbu, Bengbu 233099, China.

Department of Pathology, the First Medical Center, People's Liberation Army (PLA) General Hospital, Beijing 100853, China.

出版信息

Endocr J. 2025 Aug 1;72(8):877-885. doi: 10.1507/endocrj.EJ24-0523. Epub 2025 Apr 24.

DOI:10.1507/endocrj.EJ24-0523
PMID:40268385
原文链接:https://pmc.ncbi.nlm.nih.gov/articles/PMC12340247/
Abstract

To elucidate the clinicopathological features of follicular thyroid carcinoma (FTC) coexisting with papillary thyroid carcinoma (PTC) (FTC + PTC). We collected a total of 55 FTC + PTC patients (including 12 males [21.8%] and 43 females [78.2%]), with an average age of 47.6 years. In the FTC alone group, the average age was 52.3 years, and the proportion of females was 71.3%. The median age was 43.5 years, with an average age of 45 years in the PTC alone group. Compared with the tumors in the FTC alone group, FTC in the FTC + PTC group exhibited a smaller maximum diameter (49.1% measuring ≤2 cm), a younger patient age (70.9% younger than 55 years), an earlier tumor stage (94.5% in stages I-II), a lower incidence of recurrent cancer (n = 2, 3.6%), a lower frequency of distant metastasis (6.1%), and a lower proportion of "extensively invasive" subtype (12.7%) (all p < 0.05). Compared with the PTC alone group (n = 289), the FTC + PTC group had a higher proportion of PTC with a maximum diameter of ≤1 cm (72.5%), and the degree of invasion of thyroid extracellular tissue was less severe (all p < 0.05). No statistically significant differences were found in overall survival (OS), cancer-specific survival (CSS), and RFS between these two groups (the FTC or PTC alone group versus FTC + PTC group). In sum, FTC + PTC has some clinicopathological features.

摘要

为阐明滤泡状甲状腺癌(FTC)合并乳头状甲状腺癌(PTC)(FTC + PTC)的临床病理特征。我们共收集了55例FTC + PTC患者(包括12例男性[21.8%]和43例女性[78.2%]),平均年龄47.6岁。在单纯FTC组中,平均年龄为52.3岁,女性比例为71.3%。中位年龄为43.5岁,单纯PTC组的平均年龄为45岁。与单纯FTC组的肿瘤相比,FTC + PTC组中的FTC最大直径较小(49.1%测量值≤2 cm),患者年龄较轻(70.9%小于55岁),肿瘤分期较早(94.5%为I-II期),复发癌发生率较低(n = 2,3.6%),远处转移频率较低(6.1%),“广泛浸润性”亚型比例较低(12.7%)(所有p < 0.05)。与单纯PTC组(n = 289)相比,FTC + PTC组中最大直径≤1 cm的PTC比例更高,甲状腺细胞外组织的浸润程度较轻(所有p < 0.05)。在这两组(单纯FTC或PTC组与FTC + PTC组)之间,总生存期(OS)、癌症特异性生存期(CSS)和无复发生存期(RFS)未发现统计学显著差异。总之,FTC + PTC具有一些临床病理特征。

https://cdn.ncbi.nlm.nih.gov/pmc/blobs/d22e/12340247/b7529b29a383/72_EJ24-0523_GA.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/d22e/12340247/0a2738567649/72_EJ24-0523_01.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/d22e/12340247/bf87789a29ba/72_EJ24-0523_02.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/d22e/12340247/1ade05f5189d/72_EJ24-0523_03.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/d22e/12340247/be0036cd47d3/72_EJ24-0523_04.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/d22e/12340247/e5a00b95cabb/72_EJ24-0523_05.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/d22e/12340247/f8edcf6cbe08/72_EJ24-0523_06.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/d22e/12340247/dedabe5ca76b/72_EJ24-0523_07.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/d22e/12340247/b7529b29a383/72_EJ24-0523_GA.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/d22e/12340247/0a2738567649/72_EJ24-0523_01.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/d22e/12340247/bf87789a29ba/72_EJ24-0523_02.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/d22e/12340247/1ade05f5189d/72_EJ24-0523_03.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/d22e/12340247/be0036cd47d3/72_EJ24-0523_04.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/d22e/12340247/e5a00b95cabb/72_EJ24-0523_05.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/d22e/12340247/f8edcf6cbe08/72_EJ24-0523_06.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/d22e/12340247/dedabe5ca76b/72_EJ24-0523_07.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/d22e/12340247/b7529b29a383/72_EJ24-0523_GA.jpg

相似文献

1
Clinicopathological features of follicular thyroid carcinoma coexisting with papillary thyroid carcinoma.滤泡状甲状腺癌合并乳头状甲状腺癌的临床病理特征
Endocr J. 2025 Aug 1;72(8):877-885. doi: 10.1507/endocrj.EJ24-0523. Epub 2025 Apr 24.
2
Impact of delayed surgery in differentiated thyroid carcinoma and medullary thyroid carcinoma.延迟手术对分化型甲状腺癌和髓样甲状腺癌的影响。
Endocrine. 2025 Apr 24. doi: 10.1007/s12020-025-04241-8.
3
Prevalence of Differentiated High-Grade Thyroid Carcinoma Among Well-Differentiated Tumors: A Systematic Review and Meta-Analysis.分化型高级别甲状腺癌在分化型肿瘤中的患病率:一项系统评价和荟萃分析
Thyroid. 2024 Mar;34(3):314-323. doi: 10.1089/thy.2023.0350.
4
Prognostic Impact of Primary Tumor Size in Papillary Thyroid Carcinoma without Lymph Node Metastasis.原发性肿瘤大小对无淋巴结转移的乳头状甲状腺癌的预后影响
Endocrinol Metab (Seoul). 2025 Jun;40(3):405-413. doi: 10.3803/EnM.2024.2199. Epub 2025 Feb 25.
5
Changing Clinical Presentation of Pediatric Differentiated Thyroid Cancer in Poland: A Retrospective Cohort Study Spanning 45 Years.波兰儿童分化型甲状腺癌临床特征变迁:一项跨越 45 年的回顾性队列研究。
Thyroid. 2024 Oct;34(10):1234-1245. doi: 10.1089/thy.2024.0109. Epub 2024 Sep 25.
6
Lobectomy vs total thyroidectomy for unilateral papillary thyroid carcinoma with ipsilateral cervical lymph node metastasis.肺叶切除术与全甲状腺切除术治疗单侧甲状腺乳头状癌伴同侧颈部淋巴结转移的对比
Front Endocrinol (Lausanne). 2025 Jul 24;16:1564752. doi: 10.3389/fendo.2025.1564752. eCollection 2025.
7
Defining angioinvasion and lymphatic invasion in papillary thyroid carcinoma: morphological criteria, utility of D2-40/CD31/ERG immunohistochemistry and correlation with clinicopathological characteristics.定义甲状腺乳头状癌的血管侵犯和淋巴管侵犯:形态学标准、D2-40/CD31/ERG 免疫组化的应用及与临床病理特征的相关性。
Histopathology. 2024 Dec;85(6):950-958. doi: 10.1111/his.15285. Epub 2024 Jul 18.
8
The presence of cancerous nodules in lymph nodes is a novel indicator of distant metastasis and poor survival in patients with papillary thyroid carcinoma.淋巴结中癌结节的存在是甲状腺乳头状癌患者远处转移和预后不良的一个新指标。
J Cancer Res Clin Oncol. 2017 Jun;143(6):1035-1042. doi: 10.1007/s00432-017-2345-2. Epub 2017 Feb 15.
9
Comparative analysis of follicular cell- derived thyroid carcinoma: assessing the impact of high-grade features in an advanced disease cohort.滤泡细胞源性甲状腺癌的比较分析:评估高级别特征在晚期疾病队列中的影响。
Virchows Arch. 2025 May 2. doi: 10.1007/s00428-025-04109-2.
10
Molecular Markers in Follicular and Oncocytic Thyroid Carcinomas: Clinical Application of Molecular Genetic Testing.滤泡性和嗜酸细胞性甲状腺癌的分子标志物:分子遗传学检测的临床应用。
Curr Oncol. 2024 Oct 1;31(10):5919-5928. doi: 10.3390/curroncol31100441.

本文引用的文献

1
Chronic lymphocytic thyroiditis protects against recurrence in patients with cN0 papillary thyroid cancer.慢性淋巴细胞性甲状腺炎可降低 cN0 期甲状腺乳头状癌患者的复发风险。
Surg Oncol. 2020 Sep;34:67-73. doi: 10.1016/j.suronc.2020.03.008. Epub 2020 Apr 1.
2
Coexistence of Two Different Thyroid Malignancies: A Collision Phenomenon.两种不同甲状腺恶性肿瘤的共存:一种碰撞现象。
Cureus. 2020 Apr 4;12(4):e7539. doi: 10.7759/cureus.7539.
3
The Association Between Chronic Lymphocytic Thyroiditis and the Progress of Papillary Thyroid Cancer.
慢性淋巴细胞性甲状腺炎与甲状腺乳头状癌进展的关系。
World J Surg. 2020 May;44(5):1506-1513. doi: 10.1007/s00268-019-05337-9.
4
Clinical analysis of Hashimoto thyroiditis coexistent with papillary thyroid cancer in 1392 patients.1392例桥本甲状腺炎合并甲状腺乳头状癌患者的临床分析
Acta Otorhinolaryngol Ital. 2017 Oct;37(5):393-400. doi: 10.14639/0392-100X-1709.
5
Follicular and papillary carcinoma: a thyroid collision tumor.滤泡状癌和乳头状癌:一种甲状腺碰撞瘤。
Indian J Otolaryngol Head Neck Surg. 2013 Jul;65(Suppl 1):182-4. doi: 10.1007/s12070-011-0450-0. Epub 2012 Jan 6.